(Q53220588)

12 May 2018

reason for preferred rank

title

Improved Cellular Immune Response Elicited by a Ubiquitin-Fused DNA Vaccine AgainstMycobacterium tuberculosis (English)

1 reference

https://api.crossref.org/works/10.1089/DNA.2011.1309

12 December 2024

Improved cellular immune response elicited by a ubiquitin-fused DNA vaccine against Mycobacterium tuberculosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21905875

Mycobacterium tuberculosis

12 December 2024

main subject

0 references

author name string

Qingmin Wang

1

1 reference

12 May 2018

Chengxiang Lei

2

1 reference

12 May 2018

Hui Wan

3

1 reference

12 May 2018

Qiuhong Liu

4

1 reference

12 May 2018

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21905875

12 December 2024

publication date

9 September 2011

1 reference

12 May 2018

full work available at URL

http://www.liebertpub.com/doi/full-xml/10.1089/dna.2011.1309

1 reference

https://api.crossref.org/works/10.1089/DNA.2011.1309

http://www.liebertpub.com/doi/pdf/10.1089/dna.2011.1309

12 December 2024

1 reference

https://api.crossref.org/works/10.1089/DNA.2011.1309

12 December 2024

1 reference

12 May 2018

volume

31

1 reference

12 May 2018

issue

4

1 reference

12 May 2018

page(s)

489-495

1 reference

12 May 2018

Induction of a type 1 immune response to a recombinant antigen from Mycobacterium tuberculosis expressed in Mycobacterium vaccae

cites work

1

1 reference

https://api.crossref.org/works/10.1089/DNA.2011.1309

The success and failure of BCG - implications for a novel tuberculosis vaccine

12 December 2024

2

1 reference

https://api.crossref.org/works/10.1089/DNA.2011.1309

CpG DNA as a vaccine adjuvant.

12 December 2024

4

1 reference

https://api.crossref.org/works/10.1089/DNA.2011.1309

ESAT-6 subunit vaccination against Mycobacterium tuberculosis

12 December 2024

5

1 reference

https://api.crossref.org/works/10.1089/DNA.2011.1309

Therapeutic vaccination of rabbits with a ubiquitin-fused papillomavirus E1, E2, E6 and E7 DNA vaccine

12 December 2024

6

1 reference

https://api.crossref.org/works/10.1089/DNA.2011.1309

The Intravenous Model of Murine Tuberculosis is Less Pathogenic Than the Aerogenic Model Owing to a More Rapid Induction of Systemic Immunity

12 December 2024

7

1 reference

https://api.crossref.org/works/10.1089/DNA.2011.1309

A tuberculosis vaccine based on phosphoantigens and fusion proteins induces distinct γδ and αβ T cell responses in primates

12 December 2024

8

1 reference

https://api.crossref.org/works/10.1089/DNA.2011.1309

Genetic immunization based on the ubiquitin-fusion degradation pathway against Trypanosoma cruzi

12 December 2024

9

1 reference

https://api.crossref.org/works/10.1089/DNA.2011.1309

Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines

12 December 2024

12

1 reference

https://api.crossref.org/works/10.1089/DNA.2011.1309

Recombinant Mycobacterium smegmatis vaccine candidates

12 December 2024

13

1 reference

https://api.crossref.org/works/10.1089/DNA.2011.1309

Prevalences of Pneumocystis jiroveci, Mycobacterium tuberculosis and Streptococcus pneumoniae infection in children with severe pneumonia, in a tertiary referral hospital in northern Tanzania

12 December 2024

14

1 reference

https://api.crossref.org/works/10.1089/DNA.2011.1309

DNA vaccines against mycobacterial diseases

12 December 2024

15

1 reference

https://api.crossref.org/works/10.1089/DNA.2011.1309

The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice

12 December 2024

18

1 reference

https://api.crossref.org/works/10.1089/DNA.2011.1309

DNA immunization: ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction

12 December 2024

19

1 reference

https://api.crossref.org/works/10.1089/DNA.2011.1309

Ubiquitin conjugation of open reading frame F DNA vaccine leads to enhanced cell-mediated immune response and induces protection against both antimony-susceptible and -resistant strains of Leishmania donovani

12 December 2024

20

1 reference

https://api.crossref.org/works/10.1089/DNA.2011.1309

Expression and immunogenicity of Mycobacterium tuberculosis antigen 85 by DNA vaccination

12 December 2024

23

1 reference

https://api.crossref.org/works/10.1089/DNA.2011.1309

The N-end rule: functions, mysteries, uses

12 December 2024

24

1 reference

https://api.crossref.org/works/10.1089/DNA.2011.1309

Targeting of hepatitis C virus core protein for MHC I or MHC II presentation does not enhance induction of immune responses to DNA vaccination

12 December 2024

25

1 reference

https://api.crossref.org/works/10.1089/DNA.2011.1309

Immune response and protection elicited by DNA immunisation against Taenia cysticercosis

12 December 2024

28

1 reference

https://api.crossref.org/works/10.1089/DNA.2011.1309

Intramuscular immunization with a monogenic plasmid DNA tuberculosis vaccine: Enhanced immunogenicity by electroporation and co-expression of GM-CSF transgene

12 December 2024

29

1 reference

https://api.crossref.org/works/10.1089/DNA.2011.1309

12 December 2024

Identifiers

1 reference

12 May 2018

1 reference

12 May 2018